This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matchar, D. B. Articles by Mitchell, J. P. Search for Related Content PubMed PubMed Citation Articles by Matchar, D. B. Articles by Mitchell, J. P.

Stroke, Vol 24, 2135-2142, Copyright © 1993 by American Heart Association

ARTICLES

The Stroke Prevention Patient Outcomes Research Team. Goals and methods

DB Matchar, PW Duncan, GP Samsa, JP Whisnant, GH DeFriese, DJ Ballard, JE Paul, DM Witter Jr and JP Mitchell
Center for Health Policy Research and Education, Duke University, Durham, NC.

BACKGROUND AND PURPOSE: The aim of the present study, based at Duke University and involving 14 other institutions, is to identify the most appropriate and cost-effective clinical strategies for prevention of ischemic (thrombotic or embolic) stroke in high-risk individuals and to design and test an intervention to disseminate this information to providers and the public. METHODS: The study uses (1) secondary data from literature review, Medicare claims, and population-based data from three epidemiological studies and (2) primary data generated in national physician and patient surveys and in demonstration trials. Phases I through III involve data collection and analysis using a decision/cost-effectiveness model and consensus development methods. Phase IV includes intervention in physicians' practice patterns. Data is collected by literature survey and abstraction, review of medical records, claims analysis, and patient and physician surveys. CONCLUSIONS: A structured decision model and a well-defined clinical focus provide a successful organization for a PORT on stroke prevention.

This article has been cited by other articles:

				O. Alagoz, C. L. Bryce, S. Shechter, A. Schaefer, C.-C. H. Chang, D. C. Angus, and M. S. Roberts Incorporating Biological Natural History in Simulation Models: Empirical Estimates of the Progression of End-Stage Liver Disease Med Decis Making, November 1, 2005; 25(6): 620 - 632. [Abstract] [PDF]

				A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention Med Decis Making, November 1, 2004; 24(6): 634 - 653. [Abstract] [PDF]

				N J Cooper, A J Sutton, and K R Abrams Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section Statistical Methods in Medical Research, December 1, 2002; 11(6): 491 - 512. [Abstract] [PDF]

				G Parmigiani Measuring uncertainty in complex decision analysis models Statistical Methods in Medical Research, December 1, 2002; 11(6): 513 - 537. [Abstract] [PDF]

				G. Parmigiani, G. P. Samsa, M. Ancukiewicz, J. Lipscomb, V. Hasselblad, and D. B. Matchar Assessing Uncertainty in Cost-Effectiveness Analyses: Application to a Complex Decision Model Med Decis Making, October 1, 1997; 17(4): 390 - 401. [Abstract] [PDF]